The biology of Hodgkin's lymphoma

Hodgkin's lymphoma was first described in 1832. The aetiology of this lymphoma, however, remained enigmatic for a long time. Only within the past 10 years has the B-cell nature of the pathognomonic Hodgkin and Reed–Sternberg (HRS) cells been revealed, along with several recurrent genetic lesions. The pathogenetic role for Epstein–Barr virus infection has also been substantiated. HRS cells in classical Hodgkin's lymphoma have several characteristics that are unusual for lymphoid tumour cells, and the Hodgkin's lymphoma microenvironment is dominated by an extensive mixed, potentially inflammatory cellular infiltrate. Understanding the contribution of all of these changes to the pathogenesis of this disease is essential for the development of novel therapies.

[1]  H. Stein,et al.  Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma , 2006, Nature Immunology.

[2]  V. Diehl,et al.  Molecular single-cell analysis of Hodgkin and Reed-Sternberg cells. , 1995, Molecular medicine today.

[3]  H. Stein,et al.  Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma , 2008, Leukemia.

[4]  E. Cesarman,et al.  Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL. , 2007, Blood.

[5]  J. Kutok,et al.  Spectrum of Epstein-Barr virus-associated diseases. , 2006, Annual review of pathology.

[6]  H. Stein,et al.  Elevated NF-κB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas , 2005 .

[7]  Ralf Küppers,et al.  Mechanisms of B-cell lymphoma pathogenesis , 2005, Nature Reviews Cancer.

[8]  V. Diehl,et al.  Part II: Hodgkin's lymphoma--diagnosis and treatment. , 2004, The Lancet Oncology.

[9]  A. van den Berg,et al.  TP53 gene mutations in Hodgkin lymphoma are infrequent and not associated with absence of Epstein‐Barr virus , 2001, International journal of cancer.

[10]  R. Küppers,et al.  Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma , 2006, International journal of cancer.

[11]  T. Hodgkin.  Excerpts from: On some morbid appearances of the absorbent glands and spleen , 1973 .

[12]  K. Rajewsky,et al.  Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. , 1999, The New England journal of medicine.

[13]  W. Klapper,et al.  High expression of several tyrosine kinases and activation of the PI3K/AKT pathway in mediastinal large B cell lymphoma reveals further similarities to Hodgkin lymphoma , 2007, Leukemia.

[14]  H. Stein.  Hodgkin's Disease , 1997 .

[15]  E. Jaffe,et al.  Peripheral T-Cell Lymphomas Expressing CD30 and CD15 , 2003, The American journal of surgical pathology.

[16]  M. Busslinger,et al.  Pax5: the guardian of B cell identity and function , 2007, Nature Immunology.

[17]  S. Hamilton-Dutoit,et al.  XIAP-mediated Caspase Inhibition in Hodgkin's Lymphoma–derived B Cells , 2003, The Journal of experimental medicine.

[18]  M. Reth,et al.  Molecular mimicry of the antigen receptor signalling motif by transmembrane proteins of the Epstein-Barr virus and the bovine leukaemia virus , 1993, Current Biology.

[19]  A. van den Berg,et al.  High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma. , 1999, The American journal of pathology.

[20]  V. Diehl,et al.  Clonal Deleterious Mutations in the Iκbα Gene in the Malignant Cells in Hodgkin's Lymphoma , 2000, The Journal of experimental medicine.

[21]  Patricia A. Dyck,et al.  Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma. , 2003, Blood.

[22]  Juan F. García,et al.  Abnormal PcG protein expression in Hodgkin's lymphoma. Relation with E2F6 and NFκB transcription factors , 2004, The Journal of pathology.

[23]  I. Su,et al.  Epstein-Barr virus is associated with all histological subtypes of Hodgkin lymphoma in Vietnamese children with special emphasis on the entity of lymphocyte predominance subtype. , 2005, Human pathology.

[24]  W. Hammerschmidt,et al.  Epstein–Barr virus‐mediated B‐cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor , 1998, The EMBO journal.

[25]  V. Gattei,et al.  Interactions Between Tissue Fibroblasts in Lymph Nodes and Hodgkin/Reed-Sternberg Cells , 2004, Leukemia & lymphoma.

[26]  B. Stürzenhofecker,et al.  Dysfunctional p53 deletion mutants in cell lines derived from Hodgkin's lymphoma , 2006, Leukemia & lymphoma.

[27]  H. Takahashi,et al.  Immunophenotypes of Reed-Sternberg cells and their variants: a study of 68 cases of Hodgkin's disease. , 1995, The Tohoku journal of experimental medicine.

[28]  W. Klapper,et al.  Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma. , 2006, Blood.

[29]  H. Ohno,et al.  Stimulation of CD30 in anaplastic large cell lymphoma leads to production of nuclear factor‐κB p52, which is associated with hyperphosphorylated Bcl‐3 , 2005, Cancer science.

[30]  W. Hammerschmidt,et al.  Epstein – Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1 , which simulates an activated CD 40 receptor , 1998 .

[31]  G. Reynolds,et al.  Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells. , 2008, Blood.

[32]  V. Diehl,et al.  European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. , 2000, Blood.

[33]  A. Carbone,et al.  Expression of CCR5 receptors on Reed–Sternberg cells and Hodgkin lymphoma cell lines: Involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions , 2008, International journal of cancer.

[34]  R. Hay,et al.  Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα , 1999, Oncogene.

[35]  A. Carbone,et al.  Pathogenetic and histogenetic features of HIV-associated Hodgkin's disease. , 2001, European journal of cancer.

[36]  S. Franceschi,et al.  Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease. , 1998, Blood.

[37]  D. Baus,et al.  Specific function of STAT3, SOCS1, and SOCS3 in the regulation of proliferation and survival of classical Hodgkin lymphoma cells , 2006, International journal of cancer.

[38]  S. Pileri,et al.  Rare expression of T-cell markers in classical Hodgkin's lymphoma , 2005, Modern Pathology.

[39]  L. Young,et al.  Epstein–Barr virus and oncogenesis: from latent genes to tumours , 2003, Oncogene.

[40]  V. Godfrey,et al.  Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[41]  K. Karube,et al.  IL-21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis. , 2008, Blood.

[42]  H. Stein,et al.  Nuclear Factor (cid:2) B–dependent Gene Expression Profiling of Hodgkin’s Disease Tumor Cells, Pathogenetic Significance, and Link to Constitutive Signal Transducer and Activator of Transcription 5a Activity , 2002 .

[43]  V. Diehl,et al.  Class switch recombination was specifically targeted to immunoglobulin (Ig)G4 or IgA in Hodgkin's disease‐derived cell lines , 2001, British journal of haematology.

[44]  R. Siebert,et al.  Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma. , 2003, Blood.

[45]  Martin Zenke,et al.  Nuclear Factor κB–dependent Gene Expression Profiling of Hodgkin's Disease Tumor Cells, Pathogenetic Significance, and Link to Constitutive Signal Transducer and Activator of Transcription 5a Activity , 2002, The Journal of experimental medicine.

[46]  D. Hossfeld.  E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues , 2002 .

[47]  P. Murray,et al.  1 BMI-1 IS INDUCED BY THE EPSTEIN-BARR VIRUS ONCOGENE LMP 1 , AND REGULATES THE EXPRESSION OF VIRAL TARGET GENES IN HODGKIN ’ S LYMPHOMA CELLS , 2006 .

[48]  Mamoun Younes,et al.  MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival. , 2003, Blood.

[49]  Shigeo Mori,et al.  Ligand-independent signaling by overexpressed CD30 drives NF-κB activation in Hodgkin–Reed-Sternberg cells , 2002, Oncogene.

[50]  S. Pileri,et al.  Origin of nodular lymphocyte-predominant Hodgkin's disease from a clonal expansion of highly mutated germinal-center B cells. , 1997, The New England journal of medicine.

[51]  R. Küppers,et al.  Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma. , 2006, Haematologica.

[52]  A. Mottok,et al.  Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6. , 2007, Blood.

[53]  T. Tuschl,et al.  Tumorigenesis and Neoplastic Progression MicroRNA-Mediated Down-Regulation of PRDM 1 / Blimp-1 in Hodgkin / Reed-Sternberg Cells : A Potential Pathogenetic Lesion in Hodgkin Lymphomas , 2010 .

[54]  R. Khanna,et al.  Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma. , 2007, Blood.

[55]  V. Diehl,et al.  Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells. , 2001, Cancer research.

[56]  K. Rajewsky,et al.  The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease. , 1998, Annual review of immunology.

[57]  T. Zander,et al.  Prostaglandin E2 impairs CD4+ T cell activation by inhibition of lck: implications in Hodgkin's lymphoma. , 2006, Cancer research.

[58]  M. Drayson,et al.  Epstein-Barr virus infection in vitro can rescue germinal center B cells with inactivated immunoglobulin genes. , 2005, Blood.

[59]  K. Rajewsky,et al.  Epstein–Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[60]  Andrea Califano,et al.  Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. , 2003, The Journal of clinical investigation.

[61]  V. Diehl,et al.  Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cells , 1982, Nature.

[62]  J. Bourhis,et al.  Baseline and treatment-induced chromosomal abnormalities in peripheral blood lymphocytes of Hodgkin's lymphoma patients. , 2003, International journal of radiation oncology, biology, physics.

[63]  J. Cyster,et al.  Germinal-center organization and cellular dynamics. , 2007, Immunity.

[64]  R. Siebert,et al.  Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma. , 2002, Blood.

[65]  Toshiki Watanabe,et al.  AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells. , 2003, The American journal of pathology.

[66]  K. Rajewsky,et al.  Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma. , 2003, Cancer research.

[67]  K. Rajewsky,et al.  Rare Occurrence of Classical Hodgkin's Disease as a T Cell Lymphoma , 2000, The Journal of experimental medicine.

[68]  G. Nilsson,et al.  Mast cells express functional CD30 ligand and are the predominant CD30L‐positive cells in Hodgkin's disease , 2001, British journal of haematology.

[69]  C. Millward,et al.  Gene rearrangement and comparative genomic hybridization studies of classic Hodgkin lymphoma expressing T-cell antigens. , 2006, Archives of pathology & laboratory medicine.

[70]  T. Zander,et al.  Prostaglandin E 2 Impairs CD 4 + T Cell Activation by Inhibition of lck : Implications in Hodgkin ’ s Lymphoma , 2006 .

[71]  B. Aggarwal,et al.  Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines. , 2001, Blood.

[72]  T. Mak,et al.  The role of cytokines in classical Hodgkin lymphoma. , 2002, Blood.

[73]  S. Pileri,et al.  Aberrant expression of cell cycle regulators in Hodgkin and Reed–Sternberg cells of classical Hodgkin's lymphoma , 2005, Modern Pathology.

[74]  M. Greaves,et al.  Multilineage gene expression precedes commitment in the hemopoietic system. , 1997, Genes & development.

[75]  R. Barker,et al.  Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. , 2004, Blood.

[76]  M. Hummel,et al.  Disseminated growth of Hodgkin's-derived cell lines L540 and L540cy in immune-deficient SCID mice. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[77]  Ahmed Mansouri,et al.  Development of peripheral lymphoid organs and natural killer cells depends on the helix–loop–helix inhibitor Id2 , 1999, Nature.

[78]  S. Rose-John,et al.  Transcriptional profiling identifies Id2 function in dendritic cell development , 2003, Nature Immunology.

[79]  H. Stein,et al.  Inactivating I kappa B epsilon mutations in Hodgkin/Reed–Sternberg cells , 2003, The Journal of pathology.

[80]  L. Coussens,et al.  Humoral immunity, inflammation and cancer. , 2007, Current opinion in immunology.

[81]  S. Hamilton-Dutoit,et al.  Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma , 2002, Oncogene.

[82]  Min Ye,et al.  Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment. , 2002, Developmental cell.

[83]  I. Maclennan,et al.  Mechanism of antigen-driven selection in germinal centres , 1989, Nature.

[84]  G. Mills,et al.  Inhibition of the phosphatidylinositol‐3 kinase/Akt promotes G1 cell cycle arrest and apoptosis in Hodgkin lymphoma , 2005, British journal of haematology.

[85]  G. Lenz,et al.  Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin. , 1999, Blood.

[86]  H. Bosshart.  Interleukin-3 receptors in Hodgkin's disease. , 2003, The American journal of pathology.

[87]  H. Stein,et al.  Aberrantly expressed c‐Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF‐κB , 2002, The EMBO journal.

[88]  M. Hansmann,et al.  T-Cell Variant of Classical Hodgkin's Lymphoma with Nodal and Cutaneous Manifestations Demonstrated by Single-Cell Polymerase Chain Reaction , 2002, Laboratory Investigation.

[89]  E. Bertolino,et al.  Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5 , 2008, Nature Immunology.

[90]  K. Rajewsky,et al.  Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[91]  R. Khanna,et al.  Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients. , 2006, Blood.

[92]  P. Dirks,et al.  Cancer stem cells: at the headwaters of tumor development. , 2007, Annual review of pathology.

[93]  J. Gordon,et al.  The Epstein–Barr virus oncoprotein, latent membrane protein‐1, reprograms germinal centre B cells towards a Hodgkin's Reed–Sternberg‐like phenotype , 2008, The Journal of pathology.

[94]  H. Stein,et al.  Aberrant expression of the Th 2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT 3 signaling and attracts Treg cells via regulation of MIP-3 , 2008 .

[95]  R. Siebert,et al.  Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma. , 2006, The American journal of pathology.

[96]  R. Spang,et al.  CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells. , 2008, The American journal of pathology.

[97]  K. Rajewsky,et al.  Mutation of the p 53 Gene Is Not a Typical Feature of Hodgkin and Reed-Sternberg Cells in Hodgkin ’ s Disease , 1999 .

[98]  R. Küppers,et al.  Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas. , 2005, Blood.

[99]  J. Delabie,et al.  Expression of B7-2 (CD86) molecules by Reed–Sternberg cells of Hodgkin’s disease , 1997, Leukemia.

[100]  T. Mak,et al.  Interleukin 13 Is Secreted by and Stimulates the Growth of Hodgkin and Reed-Sternberg Cells , 1999, The Journal of experimental medicine.

[101]  T. Mattfeldt,et al.  Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation. , 2005, Oncogene.

[102]  W. Klapper,et al.  The aberrant coexpression of several receptor tyrosine kinases is largely restricted to EBV‐negative cases of classical Hodgkin's lymphoma , 2007, International journal of cancer.

[103]  G. Berrozpe,et al.  Chromosome abnormalities in peripheral blood lymphocytes from untreated Hodgkin's patients , 1988, Human Genetics.

[104]  H. Drexler,et al.  Formation of multinucleated cells in a Hodgkin's‐disease‐derived cell line , 1989, International journal of cancer.

[105]  V. Diehl,et al.  Patterned CpG methylation of silenced B cell gene promoters in classical Hodgkin lymphoma-derived and primary effusion lymphoma cell lines. , 2005, Journal of molecular biology.

[106]  R. Küppers,et al.  Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma. , 2005, Blood.

[107]  J. Goedert,et al.  Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. , 2006, Blood.

[108]  C. Meijer,et al.  Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease. , 2000, The American journal of pathology.

[109]  T. Yamagata,et al.  Notch1 inhibits differentiation of hematopoietic cells by sustaining GATA-2 expression. , 2001, Blood.

[110]  D. Huhn,et al.  Classical Hodgkin's disease and follicular lymphoma originating from the same germinal center B cell. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[111]  Tomoki Ito,et al.  Hodgkin's Reed‐Sternberg cell line (KM‐H2) promotes a bidirectional differentiation of CD4+CD25+Foxp3+ T cells and CD4+ cytotoxic T lymphocytes from CD4+ naive T cells , 2007, Journal of leukocyte biology.

[112]  J. Delabie,et al.  The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease. , 2001, The American journal of pathology.

[113]  A. van den Berg,et al.  BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas , 2005, The Journal of pathology.

[114]  H. Drexler.  Recent results on the biology of Hodgkin and Reed-Sternberg cells. I. Biopsy material. , 1992, Leukemia & lymphoma.

[115]  W. Hammerschmidt,et al.  Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival. , 2007, Blood.

[116]  G. Nilsson,et al.  Expression of CCL5/RANTES by Hodgkin and Reed‐Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue , 2003, International journal of cancer.

[117]  R Fischer,et al.  Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[118]  H. Stein,et al.  Activated Notch 1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma , 2002 .

[119]  H. Stein,et al.  Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease. , 2000, Blood.

[120]  G. Georgakis,et al.  Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines. , 2008, Blood.

[121]  V. Zagonel,et al.  Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines. , 1995, Blood.

[122]  L. Young,et al.  Constitutive activation of phosphatidyl‐inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTOR , 2005, The Journal of pathology.

[123]  H. Stein,et al.  Hodgkin/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils. , 1999, Blood.

[124]  J. Arends,et al.  Morphologically normal, CD30‐negative B‐lymphocytes with chromosome aberrations in classical Hodgkin's disease: the progenitor cell of the malignant clone? , 1999, The Journal of pathology.

[125]  Giovanna Roncador,et al.  Outcome in Hodgkin's Lymphoma Can Be Predicted from the Presence of Accompanying Cytotoxic and Regulatory T Cells , 2005, Clinical Cancer Research.

[126]  B. Jungnickel,et al.  Differential expression of activation‐induced cytidine deaminase (AID) in nodular lymphocyte‐predominant and classical Hodgkin lymphoma , 2005, The Journal of pathology.

[127]  R. Küppers,et al.  Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma. , 2009, Annual review of pathology.

[128]  R. Gascoyne,et al.  Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. , 2002, Blood.

[129]  B. Jungnickel,et al.  Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus. , 2005, Blood.

[130]  A. Carbone,et al.  Expression of functional interleukin-3 receptors on Hodgkin and Reed-Sternberg cells. , 2002, The American journal of pathology.

[131]  S. Anderson,et al.  Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. , 1998, Immunity.

[132]  J. Crocker,et al.  Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[133]  K. Savage,et al.  TRAF1 Expression and c-Rel Activation Are Useful Adjuncts in Distinguishing Classical Hodgkin Lymphoma From a Subset of Morphologically or Immunophenotypically Similar Lymphomas , 2005, The American journal of surgical pathology.

[134]  K. Rajewsky,et al.  Mutation of the p53 gene is not a typical feature of Hodgkin and Reed-Sternberg cells in Hodgkin's disease. , 1999, Blood.

[135]  F. Herrmann,et al.  Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line. , 1996, Blood.

[136]  A. Carbone,et al.  CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease. , 1995, The American journal of pathology.

[137]  C. Meijer,et al.  Unique polycomb gene expression pattern in Hodgkin's lymphoma and Hodgkin's lymphoma-derived cell lines. , 2004, The American journal of pathology.

[138]  W. Klapper,et al.  Chromosomal breakpoints affecting immunoglobulin loci are recurrent in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma. , 2006, Cancer research.

[139]  H. Rothman,et al.  Epidemiology of Hodgkin's disease , 1989, The Journal of the American Osteopathic Association.

[140]  Sergey W. Popov,et al.  Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma. , 2006, Blood.

[141]  R. Yamamoto,et al.  PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma. , 2007, Blood.

[142]  K. Rajewsky,et al.  Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. , 1993, The EMBO journal.

[143]  V. Diehl,et al.  Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. , 2003, Blood.

[144]  H. Stein,et al.  Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. , 2002, Blood.

[145]  T. Zander,et al.  RNA fingerprints provide direct evidence for the inhibitory role of TGFbeta and PD-1 on CD4+ T cells in Hodgkin lymphoma. , 2007, Blood.

[146]  H. Stein,et al.  c-FLIP Mediates Resistance of Hodgkin/Reed-Sternberg Cells to Death Receptor–induced Apoptosis , 2004, The Journal of experimental medicine.

[147]  Stefan Joos,et al.  Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. , 2002, Blood.

[148]  O. Donzé,et al.  Paracrine promotion of tumor development by the TNF ligand APRIL in Hodgkin's Disease , 2007, Leukemia.

[149]  S. Monti,et al.  The AP1-dependent secretion of galectin-1 by Reed–Sternberg cells fosters immune privilege in classical Hodgkin lymphoma , 2007, Proceedings of the National Academy of Sciences.

[150]  C. Phillips,et al.  L-428 Reed-Sternberg cells and mononuclear Hodgkin's cells arise from a single cloned mononuclear cell. , 1988, International journal of cell cloning.

[151]  I. Ernberg,et al.  Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells. , 2008, The American journal of pathology.

[152]  K. Rajewsky,et al.  EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency. , 2000, Immunity.

[153]  B. Osborne,et al.  Notch-1 Regulates NF-κB Activity in Hemopoietic Progenitor Cells1 , 2001, The Journal of Immunology.

[154]  K. Rajewsky.  Clonal selection and learning in the antibody system , 1996, Nature.

[155]  W. Klapper,et al.  Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin’s lymphoma by array-based comparative genomic hybridization , 2008, Haematologica.

[156]  Martin-Leo Hansmann,et al.  Origin and pathogenesis of nodular lymphocyte–predominant Hodgkin lymphoma as revealed by global gene expression analysis , 2008, The Journal of experimental medicine.

[157]  K. Rajewsky,et al.  Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells , 1996, The Journal of experimental medicine.

[158]  R. Siebert,et al.  Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma. , 2003, Blood.

[159]  A. Rosenwald,et al.  Comprehensive analysis of homeobox genes in Hodgkin lymphoma cell lines identifies dysregulated expression of HOXB9 mediated via ERK5 signaling and BMI1. , 2007, Blood.

[160]  T. Kelley,et al.  The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression. , 2007, American journal of clinical pathology.

[161]  V. Diehl,et al.  The early transcription factor GATA‐2 is expressed in classical Hodgkin's lymphoma , 2004, The Journal of pathology.

[162]  H. Adami,et al.  Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma. , 2007, Cancer research.

[163]  L. Gu,et al.  Transforming growth factor beta 1 messenger RNA in Reed-Sternberg cells in nodular sclerosing Hodgkin's disease. , 1995, Journal of clinical pathology.

[164]  P. Marynen,et al.  Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells. , 2000, Cancer research.

[165]  H. Stein,et al.  Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3alpha. , 2008, Blood.

[166]  H. Stein,et al.  Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. , 2001, Blood.

[167]  H. Stein,et al.  Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells. , 1999, Blood.

[168]  Klaus Rajewsky,et al.  Somatic hypermutation in normal and transformed human B cells , 1998, Immunological reviews.

[169]  V. Diehl,et al.  STAT3 is constitutively activated in Hodgkin cell lines. , 2001, Blood.